Lentiviral vectors offer gene therapy option for hemophilia A patients with anti-AAV antibodies
Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents a potential alternative ...








